image
Healthcare - Biotechnology - NASDAQ - US
$ 3.5
-0.293 %
$ 670 M
Market Cap
-8.29
P/E
ABUS - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities ABUS - Arbutus Biopharma Corporation

image
52 M
LAST VALUE
27.84%
2 YEAR CAGR
6.78%
5 YEAR CAGR
-1.53%
10 YEAR CAGR
160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025